These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37553894)

  • 1. Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
    Keenan RJ; Daykin H; Metha J; Cornthwaite-Duncan L; Wright DK; Clarke K; Oberrauch S; Brian M; Stephenson S; Nowell CJ; Allocca G; Barnham KJ; Hoyer D; Jacobson LH
    Br J Pharmacol; 2024 Jan; 181(1):87-106. PubMed ID: 37553894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
    Keenan RJ; Daykin H; Chu J; Cornthwaite-Duncan L; Allocca G; Hoyer D; Jacobson LH
    Br J Pharmacol; 2022 Jul; 179(13):3403-3417. PubMed ID: 35112344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin Receptor Antagonism Improves Sleep and Reduces Seizures in Kcna1-null Mice.
    Roundtree HM; Simeone TA; Johnson C; Matthews SA; Samson KK; Simeone KA
    Sleep; 2016 Feb; 39(2):357-68. PubMed ID: 26446112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators.
    Gotter AL; Garson SL; Stevens J; Munden RL; Fox SV; Tannenbaum PL; Yao L; Kuduk SD; McDonald T; Uslaner JM; Tye SJ; Coleman PJ; Winrow CJ; Renger JJ
    BMC Neurosci; 2014 Sep; 15():109. PubMed ID: 25242351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin OX
    Jacobson LH; Chen S; Mir S; Hoyer D
    Curr Top Behav Neurosci; 2017; 33():105-136. PubMed ID: 27909987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510.
    Keenan RJ; Oberrauch S; Bron R; Nowell CJ; Challis LM; Hoyer D; Jacobson LH
    J Alzheimers Dis; 2021; 79(2):693-708. PubMed ID: 33361602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice.
    de Oliveira P; Cella C; Locker N; Ravindran KKG; Mendis A; Wafford K; Gilmour G; Dijk DJ; Winsky-Sommerer R
    J Neurosci; 2022 Apr; 42(16):3494-3509. PubMed ID: 35273086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.
    Beuckmann CT; Ueno T; Nakagawa M; Suzuki M; Akasofu S
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30923834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.
    Gotter AL; Forman MS; Harrell CM; Stevens J; Svetnik V; Yee KL; Li X; Roecker AJ; Fox SV; Tannenbaum PL; Garson SL; Lepeleire ID; Calder N; Rosen L; Struyk A; Coleman PJ; Herring WJ; Renger JJ; Winrow CJ
    Sci Rep; 2016 Jun; 6():27147. PubMed ID: 27256922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Aging and a Dual Orexin Receptor Antagonist on Sleep Architecture and Non-REM Oscillations Including an REM Behavior Disorder Phenotype in the PS19 Mouse Model of Tauopathy.
    Kam K; Vetter K; Tejiram RA; Pettibone WD; Shim K; Audrain M; Yu L; Daehn IS; Ehrlich ME; Varga AW
    J Neurosci; 2023 Jun; 43(25):4738-4749. PubMed ID: 37230765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.
    Holton CM; Hanley N; Shanks E; Oxley P; McCarthy A; Eastwood BJ; Murray TK; Nickerson A; Wafford KA
    Alzheimers Res Ther; 2020 Jul; 12(1):84. PubMed ID: 32669112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Disruption Precedes Forebrain Synaptic Tau Burden and Contributes to Cognitive Decline in a Sex-Dependent Manner in the P301S Tau Transgenic Mouse Model.
    Martin SC; Joyce KK; Lord JS; Harper KM; Nikolova VD; Cohen TJ; Moy SS; Diering GH
    eNeuro; 2024 Jun; 11(6):. PubMed ID: 38858068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia.
    Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice.
    Kaushik MK; Aritake K; Cherasse Y; Imanishi A; Kanbayashi T; Urade Y; Yanagisawa M
    Sleep; 2021 Aug; 44(8):. PubMed ID: 33609365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
    Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
    Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: Implications for exposure therapy.
    Kobayashi I; Forcelli PA
    Behav Brain Res; 2024 Feb; 458():114741. PubMed ID: 37931704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an Orexin-2 Receptor Antagonist on Sleep and Event-Related Oscillations in Female Rats Exposed to Chronic Intermittent Ethanol During Adolescence.
    Amodeo LR; Wills DN; Sanchez-Alavez M; Ehlers CL
    Alcohol Clin Exp Res; 2020 Jul; 44(7):1378-1388. PubMed ID: 32424852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of orexin 2 receptor activation on apnea in the C57BL/6J mouse.
    Moore MW; Akladious A; Hu Y; Azzam S; Feng P; Strohl KP
    Respir Physiol Neurobiol; 2014 Aug; 200():118-25. PubMed ID: 24929062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice.
    Mahoney CE; Mochizuki T; Scammell TE
    Sleep; 2020 Jun; 43(6):. PubMed ID: 31830270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    Beuckmann CT; Suzuki H; Musiek ES; Ueno T; Sato T; Bando M; Osada Y; Moline M
    J Alzheimers Dis; 2021; 81(3):1151-1167. PubMed ID: 33843668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.